Is Biotech Ready for Another Bull Run? 3 Stocks to Get in Ahead of the Crowd
The biotech industry flourished during the height of the COVID-19 pandemic and reported record revenues and earnings last year. Despite the market slowdown, the sector is poised for another bull run, given the continued global fight against COVID-19 and the increasing demand with an aging population. Popular biotech stocks Pfizer (PFE), Bristol-Myers Squibb (BMY), and […]